Response to pneumococcal vaccination in normal and post-infected Nigerians

Area of Science:

• Immunology
• Infectious Diseases
• Vaccinology

Background:

• Pneumococcal infections pose a significant public health burden.
• Understanding immune response post-infection is crucial for vaccine strategies.
• Herd immunity relies on widespread population immunity.

Purpose of the Study:

• To compare the immune response to polyvalent pneumococcal vaccine in patients recovered from pneumococcal infection versus healthy controls.
• To investigate the duration of potential vaccine unresponsiveness after pneumococcal infection.

Main Methods:

• Radioimmunoassay was used to quantify antibody levels.
• Polyvalent pneumococcal vaccine was administered to 12 recovered patients and 12 household controls.
• Antibody response to nine pneumococcal polysaccharides was measured before and after immunization.

Main Results:

• Both patients and controls had adequate pre-immunization antibody levels.
• Healthy controls demonstrated a stronger antibody response to pneumococcal polysaccharides than patients.
• A transient state of unresponsiveness to the vaccine was observed in patients 4-6 weeks post-infection.

Conclusions:

• Patients recovering from pneumococcal infections may experience a temporary period of reduced vaccine responsiveness.
• This transient unresponsiveness could have implications for achieving adequate herd immunity against pneumococcal serotypes.
• Further research is needed to define the duration and mechanisms of this post-infectious immune modulation.